Unbound MEDLINE

Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1. Acta haematologica [Acta Haematol] Journal article

 
TitleLaboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1.
Author(s)Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van Vliet HH 
InstitutionHemostasis and Thrombosis Research Center, Antwerp University Hospital, Edegem, Belgium.
SourceActa Haematol 2009; 121(2-3):85-97.
AbstractMild type 1 von Willebrand disease (VWD) is characterized by low to variable penetrance of bleeding, a high (increased) prevalence of blood group O, von Willebrand factor (VWF) values around and above 30% with normal ratios of VWF:ristocetin cofactor activity (RCo)/VWF:antigen (Ag), VWF:collagen binding (CB)/VWF:Ag and factor VIII (FVIII):coagulant activity (C)/VWF:Ag. Within this group of patients, the combination of the C1584 mutation and blood group O is rather frequent. Patients with mild VWD type 1 present good/normal responses of FVIII:C and VWF parameters to desmopressin (DDAVP). With the exclusion of dominant VWD type Vicenza, type 1/2E, recessive 2N and dominant 2M, missense mutations in patients with mild VWD type 1 with normal multimers are mainly located in the regulatory sequence region, the D1/D2 propeptide region, the D' VWF-FVIII binding site region and the D4, B1-B3 and C1-C2 domains but rarely in the D3, A1 or A2 domain. A new category of either dominant or recessive mild VWD type 1 due to mutations in the D4, B1-B3 and C1-C2 domains of the VWF gene consists of two groups: one group with mild VWD with normal VWF multimers and a second group with mild/moderate VWD with smeary multimer pattern.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19506353
  
Advertise on this site.